Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)
Se‐Il Go, Sang‐Cheol Lee, Woo Kyun Bae, Dae Young Zang, Hyun Woo Lee, Joung Soon Jang, Jun Ho Ji, Jung Hoon Kim, Sang-Gon Park, Sun Jin Sym, Yaewon Yang, So Yeon Jeon, In Gyu Hwang, Sung Yong Oh, Jung Hun Kang
Topics & Concepts
MedicineFOLFIRINOXGemcitabineOxaliplatinInternal medicineHazard ratioClinical endpointIrinotecanGastroenterologyChemotherapyConfidence intervalPancreatic cancerAdverse effectAdenocarcinomaSurgeryRandomized controlled trialCancerColorectal cancerPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesNeuroendocrine Tumor Research Advances